• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Jazz Pharmaceuticals plc - Ordinary Shares (NQ:JAZZ)

    233.01 +1.49 (+0.64%)
    Delayed Quote Updated: 4:00 PM EDT, Oct 1, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 740,576
    Open 230.33
    Bid (Size) 232.99 (100)
    Ask (Size) 233.14 (100)
    Prev. Close 231.52
    Today's Range 229.85 - 234.47
    52wk Range 128.49 - 266.38
    Shares Outstanding 62,311,104
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Q2 Earnings Outperformers: Jazz Pharmaceuticals (NASDAQ:JAZZ) And The Rest Of The Pharmaceuticals Stocks
    As the Q2 earnings season wraps, let’s dig into this quarter’s best and worst performers in the pharmaceuticals industry, including Jazz Pharmaceuticals (NAS... 
    Via StockStory
    Topics Artificial Intelligence Intellectual Property
    Cannabis Stocks: A Profitability Turnaround Is Brewing Beneath Weak Price Action ↗
    Via Chartmill
    Topics Cannabis

    Performance

    YTD
    +34.6%
    +34.6%
    1 Month
    -7.0%
    -7.0%
    3 Month
    -1.9%
    -1.9%
    6 Month
    +23.8%
    +23.8%
    1 Year
    +76.8%
    +76.8%

    More News

    Read More
    News headline image
    Jazz Pharmaceuticals Targets $5B Zanidatamab Opportunity as Oncology Revenue Tops $1B ↗
    Via MarketBeat
    Topics Cannabis
    News headline image
    Jazz Pharmaceuticals Sees $3B-$5B Ziihera Opportunity as Pipeline Expands ↗
    Via MarketBeat
    Topics Cannabis
    Jazz Pharmaceuticals (NASDAQ:JAZZ): A Decent Value Stock Trading Below Its Worth ↗
    Via Chartmill
    Cannabis Rally Turns Selective as Investors Reward Pharma-Tinged Names ↗
    Via Chartmill
    Topics Cannabis
    Jazz Pharmaceuticals (NASDAQ:JAZZ): A Decent Value Opportunity ↗
    Via Chartmill
    Cannabis Theme's Hidden Strength: Established Players Outshining Pure Plays ↗
    Via Chartmill
    Topics Cannabis
    News headline image
    Should You Buy Jazz Pharmaceuticals Stock After Its Actio Acquisition? ↗
    Via The Motley Fool
    News headline image
    3 Cash-Producing Stocks We’re Skeptical Of
    Via StockStory
    Topics Retirement
    News headline image
    2 Reasons to Avoid JAZZ and 1 Stock to Buy Instead
    Via StockStory
    Topics Stocks
    News headline image
    1 Value Stock with Exciting Potential and 2 We Brush Off
    Via StockStory
    Topics Energy Retirement
    Cannabis Theme Rally Powered by Profitability, Not Pure-Play Speculation ↗
    Via Chartmill
    Topics Cannabis
    News headline image
    Stocks making big moves yesterday: Jazz Pharmaceuticals, SAIC, Herbalife, AGCO, and Deere
    Via StockStory
    News headline image
    Jazz Pharmaceuticals (JAZZ) Stock Trades Up, Here Is Why
    Via StockStory
    Topics Artificial Intelligence
    News headline image
    Jazz Pharmaceuticals Launches Ziihera After FDA Nod in HER2-Positive GEA ↗
    Via MarketBeat
    Topics Cannabis
    News headline image
    3 Profitable Stocks with Questionable Fundamentals
    Via StockStory
    Topics Economy
    News headline image
    Jazz Pharmaceuticals (JAZZ) Q2 2026 Earnings Call Transcript ↗
    Via The Motley Fool
    Topics Earnings
    News headline image
    5 Revealing Analyst Questions From Jazz Pharmaceuticals’s Q2 Earnings Call
    Via StockStory
    Topics Earnings
    News headline image
    Jazz Pharmaceuticals Q2 Earnings Call Highlights ↗
    Via MarketBeat
    Topics Cannabis Earnings
    News headline image
    Jazz Pharmaceuticals (NASDAQ:JAZZ) Reports Bullish Q2 CY2026, Guides for Strong Full-Year Sales
    Via StockStory
    News headline image
    Jazz Pharmaceuticals (JAZZ) Q2 Earnings: What To Expect
    Via StockStory
    Topics Artificial Intelligence
    News headline image
    3 Value Stocks with Open Questions
    Via StockStory
    News headline image
    3 Overrated Stocks Walking a Fine Line
    Via StockStory
    News headline image
    Jazz Pharmaceuticals' Lung Cancer Drug Setback in Late-Stage Trials: Here's Why the Stock Impact May Be More Limited Than It Looks ↗
    Via The Motley Fool

    Frequently Asked Questions

    Is Jazz Pharmaceuticals plc - Ordinary Shares publicly traded?
    Yes, Jazz Pharmaceuticals plc - Ordinary Shares is publicly traded.
    What exchange does Jazz Pharmaceuticals plc - Ordinary Shares trade on?
    Jazz Pharmaceuticals plc - Ordinary Shares trades on the Nasdaq Stock Market
    What is the ticker symbol for Jazz Pharmaceuticals plc - Ordinary Shares?
    The ticker symbol for Jazz Pharmaceuticals plc - Ordinary Shares is JAZZ on the Nasdaq Stock Market
    What is the current price of Jazz Pharmaceuticals plc - Ordinary Shares?
    The current price of Jazz Pharmaceuticals plc - Ordinary Shares is 233.01
    When was Jazz Pharmaceuticals plc - Ordinary Shares last traded?
    The last trade of Jazz Pharmaceuticals plc - Ordinary Shares was at 10/01/26 04:00 PM ET
    What is the market capitalization of Jazz Pharmaceuticals plc - Ordinary Shares?
    The market capitalization of Jazz Pharmaceuticals plc - Ordinary Shares is 14.52B
    How many shares of Jazz Pharmaceuticals plc - Ordinary Shares are outstanding?
    Jazz Pharmaceuticals plc - Ordinary Shares has 15B shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.